FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion

Haijun Zhang, Yunqian Pan, Li Zheng, Chungyoul Choe, Bruce Lindgren, Eric D. Jensen, Jennifer J Westendorf, Liang Cheng, Haojie Huang

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Prostate cancer patients with regional lymph node involvement at radical prostatectomy often experience disease progression to other organs, with the bone as the predominant site. The transcription factor Runx2 plays an important role in bone formation and prostate cancer cell migration, invasion, and metastasis. Here we showed that the forkhead box O (FOXO1) protein, a key downstream effector of the tumor suppressor PTEN, inhibits the transcriptional activity of Runx2 in prostate cancer cells. This inhibition was enhanced by PTEN but diminished by active Akt. FOXO1 bound to Runx2 in vitro and in vivo and suppressed Runx2's activity independent of its transcriptional function. FOXO1 inhibited Runx2-promoted migration of prostate cancer cells, whereas silencing of endogenous FOXO1 enhanced prostate cancer cell migration in a Runx2-dependent manner. Forced expression of FOXO1 also inhibited Runx2-promoted prostate cancer cell invasion. Finally, we found that expression of PTEN and the level of FOXO1 in the nucleus is inversely correlated with expression of Runx2 in a cohort of prostate cancer specimens from patients with lymph node and bone metastasis. These data reveal FOXO1 as a critical negative regulator of Runx2 in prostate cancer cells. Inactivation of FOXO1 due to frequent loss of PTEN in prostate cancer cells may leave the oncogenic activities of Runx2 unchecked, thereby driving promiscuous expression of Runx2 target genes involved in cell migration and invasion and favoring prostate cancer progression.

Original languageEnglish (US)
Pages (from-to)3257-3267
Number of pages11
JournalCancer Research
Volume71
Issue number9
DOIs
StatePublished - May 1 2011

Fingerprint

Cell Movement
Prostatic Neoplasms
Lymph Nodes
Neoplasm Metastasis
Bone and Bones
Bone Neoplasms
Prostatectomy
Osteogenesis
Disease Progression
Transcription Factors
Genes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion. / Zhang, Haijun; Pan, Yunqian; Zheng, Li; Choe, Chungyoul; Lindgren, Bruce; Jensen, Eric D.; Westendorf, Jennifer J; Cheng, Liang; Huang, Haojie.

In: Cancer Research, Vol. 71, No. 9, 01.05.2011, p. 3257-3267.

Research output: Contribution to journalArticle

Zhang, Haijun ; Pan, Yunqian ; Zheng, Li ; Choe, Chungyoul ; Lindgren, Bruce ; Jensen, Eric D. ; Westendorf, Jennifer J ; Cheng, Liang ; Huang, Haojie. / FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion. In: Cancer Research. 2011 ; Vol. 71, No. 9. pp. 3257-3267.
@article{36e1215981414afe8f2df6fd2ffe2839,
title = "FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion",
abstract = "Prostate cancer patients with regional lymph node involvement at radical prostatectomy often experience disease progression to other organs, with the bone as the predominant site. The transcription factor Runx2 plays an important role in bone formation and prostate cancer cell migration, invasion, and metastasis. Here we showed that the forkhead box O (FOXO1) protein, a key downstream effector of the tumor suppressor PTEN, inhibits the transcriptional activity of Runx2 in prostate cancer cells. This inhibition was enhanced by PTEN but diminished by active Akt. FOXO1 bound to Runx2 in vitro and in vivo and suppressed Runx2's activity independent of its transcriptional function. FOXO1 inhibited Runx2-promoted migration of prostate cancer cells, whereas silencing of endogenous FOXO1 enhanced prostate cancer cell migration in a Runx2-dependent manner. Forced expression of FOXO1 also inhibited Runx2-promoted prostate cancer cell invasion. Finally, we found that expression of PTEN and the level of FOXO1 in the nucleus is inversely correlated with expression of Runx2 in a cohort of prostate cancer specimens from patients with lymph node and bone metastasis. These data reveal FOXO1 as a critical negative regulator of Runx2 in prostate cancer cells. Inactivation of FOXO1 due to frequent loss of PTEN in prostate cancer cells may leave the oncogenic activities of Runx2 unchecked, thereby driving promiscuous expression of Runx2 target genes involved in cell migration and invasion and favoring prostate cancer progression.",
author = "Haijun Zhang and Yunqian Pan and Li Zheng and Chungyoul Choe and Bruce Lindgren and Jensen, {Eric D.} and Westendorf, {Jennifer J} and Liang Cheng and Haojie Huang",
year = "2011",
month = "5",
day = "1",
doi = "10.1158/0008-5472.CAN-10-2603",
language = "English (US)",
volume = "71",
pages = "3257--3267",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

TY - JOUR

T1 - FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion

AU - Zhang, Haijun

AU - Pan, Yunqian

AU - Zheng, Li

AU - Choe, Chungyoul

AU - Lindgren, Bruce

AU - Jensen, Eric D.

AU - Westendorf, Jennifer J

AU - Cheng, Liang

AU - Huang, Haojie

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Prostate cancer patients with regional lymph node involvement at radical prostatectomy often experience disease progression to other organs, with the bone as the predominant site. The transcription factor Runx2 plays an important role in bone formation and prostate cancer cell migration, invasion, and metastasis. Here we showed that the forkhead box O (FOXO1) protein, a key downstream effector of the tumor suppressor PTEN, inhibits the transcriptional activity of Runx2 in prostate cancer cells. This inhibition was enhanced by PTEN but diminished by active Akt. FOXO1 bound to Runx2 in vitro and in vivo and suppressed Runx2's activity independent of its transcriptional function. FOXO1 inhibited Runx2-promoted migration of prostate cancer cells, whereas silencing of endogenous FOXO1 enhanced prostate cancer cell migration in a Runx2-dependent manner. Forced expression of FOXO1 also inhibited Runx2-promoted prostate cancer cell invasion. Finally, we found that expression of PTEN and the level of FOXO1 in the nucleus is inversely correlated with expression of Runx2 in a cohort of prostate cancer specimens from patients with lymph node and bone metastasis. These data reveal FOXO1 as a critical negative regulator of Runx2 in prostate cancer cells. Inactivation of FOXO1 due to frequent loss of PTEN in prostate cancer cells may leave the oncogenic activities of Runx2 unchecked, thereby driving promiscuous expression of Runx2 target genes involved in cell migration and invasion and favoring prostate cancer progression.

AB - Prostate cancer patients with regional lymph node involvement at radical prostatectomy often experience disease progression to other organs, with the bone as the predominant site. The transcription factor Runx2 plays an important role in bone formation and prostate cancer cell migration, invasion, and metastasis. Here we showed that the forkhead box O (FOXO1) protein, a key downstream effector of the tumor suppressor PTEN, inhibits the transcriptional activity of Runx2 in prostate cancer cells. This inhibition was enhanced by PTEN but diminished by active Akt. FOXO1 bound to Runx2 in vitro and in vivo and suppressed Runx2's activity independent of its transcriptional function. FOXO1 inhibited Runx2-promoted migration of prostate cancer cells, whereas silencing of endogenous FOXO1 enhanced prostate cancer cell migration in a Runx2-dependent manner. Forced expression of FOXO1 also inhibited Runx2-promoted prostate cancer cell invasion. Finally, we found that expression of PTEN and the level of FOXO1 in the nucleus is inversely correlated with expression of Runx2 in a cohort of prostate cancer specimens from patients with lymph node and bone metastasis. These data reveal FOXO1 as a critical negative regulator of Runx2 in prostate cancer cells. Inactivation of FOXO1 due to frequent loss of PTEN in prostate cancer cells may leave the oncogenic activities of Runx2 unchecked, thereby driving promiscuous expression of Runx2 target genes involved in cell migration and invasion and favoring prostate cancer progression.

UR - http://www.scopus.com/inward/record.url?scp=79955520485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955520485&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-10-2603

DO - 10.1158/0008-5472.CAN-10-2603

M3 - Article

C2 - 21505104

AN - SCOPUS:79955520485

VL - 71

SP - 3257

EP - 3267

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 9

ER -